TABLE 2.

DRLs (MBq) in Kuwait Compared with Other Countries as Reported in the Literature

Scan	Radiopharmaceutical	Kuwait	Korea	Japan	Australia	U.K.	Brazil	United States (27)	European Union (28)
Tumor	¹⁸F-FDG	230	370	240	310	400	370	461–710	200–400
Brain	¹⁸F-FDG	231	370	240	250	250	350	—	—
Bone	^99mTc-diphosphonate	944	925	950	920	600	1,110	848–1,185	500–1,110
Leukocyte	^99mTc-HMPAO-WBC	892.5	888	—	800	200	—	—	300–600
Thyroid	^99mTc-pertechnetate	185	217	300	215	80	444	—	75–222
Thyroid carcinoma	¹³¹I-NaI	200	185	—	185	400	185	—	90–400
Parathyroid	^99mTc-MIBI	900	740	800	900	900	740	—	400–900
Brain	^99mTc-HMPAO	892.5	925	800	750	750	1,203	887–1,294	500–1,110
Cardiac	^99mTc-MIBI or TF (MPI, rest)	976	555	900	620	800	444	519–1,153	560
Cardiac	^99mTc-MIBI or TF (MPI, stress)	976	1,110	1,200	1,520	800	1,110	945–1,402	1,100
Cardiac	^99mTc-RBC	740	740	—	1,030	800	—	916–1,301	600–1,000
Lung perfusion	^99mTc-MAA	217.5	222	260	240	100	333	147–226	100–296
Lymphangioscintigraphy	^99mTc-phytate	40	148		52	40	74	—	74–150
Hepatobiliary	^99mTc-phytate	210	185	200	200	80	370	110–259	—
Salivary	^99mTc-pertechnetate	370	370	370	200	80	555	—	—
Gastric emptying	^99mTc-DTPA	37	111	—	44	12	—	31–50	150–540
Renal dynamic	^99mTc-DTPA	90	555	400	500	300	449	407–587	—
Renal dynamic	^99mTc-MAG3	370	500	400	305	100	—	283–379	100–370
Renal static	^99mTc-DMSA	200	185	210	200	80	185	189–289	70–183
Radionuclide cystography	^99mTc-pertechnetate	94	74	—	94	25	—	—	—